top of page
Website Badges (3).png
xCures
Precision oncology platform capturing real-world evidence & slashing drug development time
INVESTMENt

June, 2019

Sector

Pharma-Tech

FUND

Fund 1

location

Northern California

co-investors

Vanedge Capital
Metaplanet Holdings

Sonia Szamocki 32co ceo

Mika Newton

CEO

Alertive.png
Quintuple aim

xCures platform transforms complex unstructured medical data directly from the patient’s medical records into structured data suitable for analysis and machine learning. Their A.I. engine then actively cross-references this data against the vast digital library of oncology data to match patients with potential treatments and predict outcomes. This empowers patients and their oncologists to make more informed and effective treatment decisions.

WM360_logo-18.png
bottom of page